Novavax Inc

MD · United States · Reporting entity ID 100001281931

Total reported 2019–2025

$92.3M

#102 of 2,960 reporting companies — 0.1% of all reported industry payments

$484K in general payments across 509 records, plus $91.8M in research funding across 7,092 records.

How it breaks down

General payments $484,277

Research funding $91,802,008

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.